Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Briefing
  • Published:

A phenotypic screen enables high-throughput target-first discovery of molecular glue degraders

A new screen platform named DEFUSE (DEath FUSion Escape) enables high-throughput discovery of small molecule protein degraders. DEFUSE identified SKPer1, a molecule that works by inducing proximity between an oncogenic driver and an E3 ligase, opening new avenues for targeted protein degradation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: A schematic representation of the DEFUSE system.

References

  1. Dale, B. et al. Advancing targeted protein degradation for cancer therapy. Nat. Rev. Cancer 21, 638–654 (2021). This review discusses molecular glue degraders as potential solutions for ‘undruggable’ disease drivers.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  2. Schapira, M., Calabrese, M. F., Bullock, A. N. & Crews, C. M. Targeted protein degradation: expanding the toolbox. Nat. Rev. Drug Discov. 18, 949–963 (2019). This review discusses the advantage of targeted protein degraders over traditional occupancy-based inhibitors.

    Article  PubMed  CAS  Google Scholar 

  3. Hinterndorfer, M. et al. Targeted protein degradation for cancer therapy. Nat. Rev. Cancer https://doi.org/10.1038/s41568-025-00817-8 (2025). This review summarizes various TPD modalities and their prospects as new cancer therapeutics.

    Article  PubMed  Google Scholar 

  4. Mayor-Ruiz, C. et al. Rational discovery of molecular glue degraders via scalable chemical profiling. Nat. Chem. Biol. 16, 1199–1207 (2020). This study presents the discovery and characterization of a molecular glue degrader of cyclin K.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  5. Garber, K. The glue degraders. Nat. Biotechnol. 42, 546–550 (2024). This news feature profiles approaches to discovering molecular glue degraders.

    Article  PubMed  CAS  Google Scholar 

Download references

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This is a summary of: Chu, Y. et al. A rapid imaging-based screen for induced-proximity degraders identifies a potent degrader of oncoprotein SKP2. Nat. Biotechnol. https://doi.org/10.1038/s41587-025-02793-8 (2025).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

A phenotypic screen enables high-throughput target-first discovery of molecular glue degraders. Nat Biotechnol (2025). https://doi.org/10.1038/s41587-025-02794-7

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/s41587-025-02794-7

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer